Jose Antonio Mira Escarti

Profesor Asociado CIS
jmira@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: Sin Grupo
Tipo Año Título Fuente
Artículo2016 Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Artículo2016 Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort PLOS ONE
Artículo2015 Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2015 Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfection ANTIVIRAL THERAPY
Artículo2014 A 24-Week Treatment Strategy With Pegylated Interferon/Ribavirin in HIV/Hepatitis C Virus Genotype 3-Coinfected Patients Who Achieved a Rapid Virologic Response Results in a High Sustained Virologic Response Rate CLINICAL INFECTIOUS DISEASES
Artículo2014 A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers LIVER INTERNATIONAL
Artículo2014 Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection ARCHIVES OF VIROLOGY
Artículo2014 Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment JOURNAL OF CLINICAL MICROBIOLOGY
Artículo2013 Atazanavir-Based Therapy Is Associated with Higher Hepatitis C Viral Load in HIV Type 1-Infected Subjects with Untreated Hepatitis C AIDS RESEARCH AND HUMAN RETROVIRUSES
Artículo2013 Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV INFECTION
Artículo2013 Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/Hepatitis C virus-coinfected patients with compensated cirrhosis CLINICAL INFECTIOUS DISEASES
Artículo2013 Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves JOURNAL OF MEDICAL VIROLOGY
Artículo2013 Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Artículo2013 Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response JOURNAL OF INFECTION
Artículo2013 Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Editorial2012 ¿Podemos adelantar el diagnóstico de la respuesta virológica sostenida a las 12 semanas tras finalizar el tratamiento frente al VHC? ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2012 Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2012 Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2012 Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients AIDS
Artículo2012 HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection ANTIVIRAL RESEARCH
Artículo2012 Prevalencia de los marcadores de infección de los virus de las hepatitis en pacientes portadores del VIH en el sur de España ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2012 Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis CLINICAL INFECTIOUS DISEASES
Artículo2011 Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients HIV MEDICINE
Artículo2011 Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype HIV MEDICINE
Artículo2011 Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV-hepatitis C virus-coinfected patients with prior nonresponse or relapse AIDS
Artículo2011 Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011 Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2010 Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients AIDS
Artículo2010 Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2010 Concomitant nevirapine therapy is associated with higher efficacy of pegylated interferon plus ribavirin among HIV/ hepatitis C Virus-Coinfected patients Journal of AIDS and Clinical Research
Artículo2010 Haart and the liver: friend or foe? EUROPEAN JOURNAL OF MEDICAL RESEARCH
Artículo2010 Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometry EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Artículo2010 Nevirapine-based antiretroviral therapy is associated with lower plasma hepatitis C virus viral load among HIV/ hepatitis C Virus-Coinfected patients Journal of AIDS and Clinical Research
Artículo2010 Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus CLINICAL INFECTIOUS DISEASES
Artículo2010 Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine ANTIVIRAL THERAPY
Revisión2009 A review of current anti-HCV treatment regimens and possible future strategies EXPERT OPINION ON PHARMACOTHERAPY
Artículo2009 Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression CLINICAL INFECTIOUS DISEASES
Revisión2009 Esteatosis hepática no alcohólica en la infección por el virus de la inmunodeficiencia humana MEDICINA CLINICA
Artículo2009 Fast Fibrosis Progression Between Repeated Liver Biopsies in Patients Coinfected with Human Immunodeficiency Virus/Hepatitis C Virus HEPATOLOGY
Artículo2009 Impact of Observer Experience on the Reproducibility of Transient Elastometry in HIV/HCV Co-infected Patients HIV CLINICAL TRIALS
Artículo2009 Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients JOURNAL OF HEPATOLOGY
Artículo2008 Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients AIDS
Artículo2008 Changes in liver-related hospital admissions and hospital mortality among HIV-infected patients (1998 to 2005) ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2008 Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008 Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008 High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack LIVER INTERNATIONAL
Artículo2008 Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008 Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir ANTIVIRAL THERAPY
Letter2007 Artritis por Mycobacterium kansasii en una mujer infectada por el virus de la inmunodeficiencia humana ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2007 Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Revisión2007 Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2007 Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2007 Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients ANTIVIRAL THERAPY
Artículo2007 Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients ANTIVIRAL THERAPY
Artículo2006 Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C ANTIVIRAL THERAPY
Artículo2006 Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2006 Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients JOURNAL OF VIRAL HEPATITIS
Letter2006 Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2006 Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes GUT
Letter2005 Antiretroviral therapy and liver fibrosis in HIV-infected patients with chronic hepatitis C HEPATOLOGY
Artículo2005 Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus coinfection JOURNAL OF INFECTIOUS DISEASES
Artículo2005 Prevalencia de anticuerpos séricos frente a Bartonella spp. en una población sana del área sur de la provincia de Sevilla REVISTA CLINICA ESPANOLA
Artículo2005 Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy AIDS RESEARCH AND HUMAN RETROVIRUSES
Artículo2005 Transient rebounds of hiv plasma vieremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy JOURNAL OF INFECTION
Artículo2004 Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy HIV MEDICINE
Artículo2004 Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine AIDS
Artículo2004 Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
Artículo2004 Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment ANTIVIRAL THERAPY
Letter2004 Prevalence of non-significant liver fibrosis and rate of fibrosis progression in HIV/hepatitis C virus-co-infected patients: still a role for liver biopsy? AIDS
Letter2004 Relapsing blepharitis in patients under highly active antiretroviral therapy including indinavir AIDS
Artículo2003 Bone involvement and abcess formation by neutrophil-rich CD30+anaplastic large-cell lymphoma mimicking skeletal infection in an AIDS patient JOURNAL OF INFECTION
Artículo2003 Impaired recovery of CD4+cell counts following highly active antiretroviral therapy in drug-naive patients coinfected with human immunodeficiency virus and hepatitis C virus EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2003 Influence of hepatitis C virus coinfection on failure of HIV-infected patients receiving highly active antiretroviral therapy to achieve normal serum beta 2microglobulin levels EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2003 Kinetics of Bartonella spp. IgG antibodies in cat-scratch disease and in asymptomatic HIV-infected patients MEDICINA CLINICA
Artículo2003 Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients HIV CLINICAL TRIALS
Artículo2002 Factors related to the chronicity and evolution of hepatitis C infection in patients co-infected by the human immunodeficiency virus CLINICAL MICROBIOLOGY AND INFECTION
Artículo2002 Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy JOURNAL OF CLINICAL MICROBIOLOGY
Artículo2002 Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2002 Prevalencia de seropositividad para Bartonella spp. en pacientes adictos a drogas por vía parenteral infectados y no infectados por el virus de la inmunodeficiencia humana MEDICINA CLINICA
Artículo2002 Transient rebounds of low-level viraemia among HIV-infected patients under HAART are not associated with virological or immunological failure ANTIVIRAL THERAPY
Artículo2001 Evidence of increased risk for Leishmania infantum infection among HIV-seronegative intravenous drug users from southern Spain EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2001 Extracellular enzymatic activity in 11 Cryptococcus species MYCOPATHOLOGIA
Artículo2001 Hiperhidrosis y nódulos múltiples en pelos axilares ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2001 Onychomycosis caused by Aspergillus sclerotiorum JOURNAL DE MYCOLOGIE MEDICALE
Letter2000 Candidiasis vulvovaginal resistente a azoles ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2000 Onicomicosis por hongos filamentosos no dermatófitos en Cádiz ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2000 Susceptibility of Streptococcus pyogenes to penicillin, macrolides and clindamycin in Cadiz Revista Española de Quimioterapia
Artículo1999 Case of onychomycosis caused by Microsporum racemosum JOURNAL OF CLINICAL MICROBIOLOGY
Letter1999 Fusariamperitonitis in a patient on peritoneal dialysis [2] REVISTA IBEROAMERICANA DE MICOLOGIA
Letter1999 Infection by Neisseria spp. Three cases [3] ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo1999 Otomycosis of uncommon etiology ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo1998 Identificación de levaduras de interés clínico en el medio de cultivo CHROMagar Candida REVISTA IBEROAMERICANA DE MICOLOGIA
Artículo1998 Isolation of Hanseniaspora uvarum (Kloeckera apiculata) in humans MYCOPATHOLOGIA
Artículo1997 Endophthalmitis in a patient from a rural environment ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo1997 Increase in high resistance to penicillin of clinical isolates of streptococcus pneumoniae in cádiz, Spain CHEMOTHERAPY
Artículo1997 Onychoprotothecosis due to Prototheca wickerhamii MYCOPATHOLOGIA
Revisión1997 Protothecosis: Clinical and therapeutic aspects ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Letter1996 Saccharomyces cerevisiae vaginitis ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo1996 Sexual forms of yeasts in clinical samples MYCOPATHOLOGIA
Artículo1996 Urinary tract infection by Haemophilus in paediatrics: A rarely studied pathology ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo1995 Spectrum of parvovirus B19 infection: Analysis of an outbreak of 43 cases in cadiz, Spain CLINICAL INFECTIOUS DISEASES
Letter1994 Bacteremias caused by Streptococcus agalactiae in adults ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Revisión1994 Human infection by parvovirus B19 ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Letter1994 Pneumonia by Pneumocystis carinii in an immunosuppressed infant [6] ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo1993 Analysis of 40 cases of otomycosis ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Letter1993 Bullous erythema multiforme caused by human parvovirus B19 ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Letter1993 Candida lipolytica, a new opportunistic pathogen ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Letter1993 Endocarditis por Capnocytophaga spputigena ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Este investigador no ha dirigido/tutorizado tesis
El investigador no tiene ningún proyecto asociado